
Multicenter GLORIA Trial: Dual Inhibition of CXCL12 and VEGF Alongside Radiotherapy in Newly Diagnosed Glioblastoma
Patients with newly diagnosed glioblastoma carrying an unmethylated MGMT promoter and incomplete resection face a particularly unfavorable prognosis,…
Read more




